{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:39:21Z","timestamp":1793691561654,"version":"4.5.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Nodthera"},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR061491"],"award-info":[{"award-number":["AR061491"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-026-03731-4","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:34:37Z","timestamp":1771670077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CNS-targeted NLRP3 Inhibition by NT-0527 confers therapeutic advantage in a CAPS mouse model"],"prefix":"10.1186","volume":"23","author":[{"given":"Beverly H.","family":"Koller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MyTrang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Doedens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan P.","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Gabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,21]]},"reference":[{"issue":"1","key":"3731_CR1","doi-asserted-by":"publisher","first-page":"e13406","DOI":"10.1111\/imr.13406","volume":"329","author":"A Pandey","year":"2024","unstructured":"Pandey A, Li Z, Gautam M, Ghosh A, Man SM. Molecular mechanisms of emerging inflammasome complexes and their activation and signaling in inflammation and pyroptosis. Immunol Rev. 2024;329(1):e13406. https:\/\/doi.org\/10.1111\/imr.13406.","journal-title":"Immunol Rev"},{"key":"3731_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1146\/annurev-immunol-101320-011235","volume":"40","author":"K Nozaki","year":"2022","unstructured":"Nozaki K, Li L, Miao EA. Innate sensors trigger regulated cell death to combat intracellular infection. Annu Rev Immunol. 2022;40:469\u201398. https:\/\/doi.org\/10.1146\/annurev-immunol-101320-011235.","journal-title":"Annu Rev Immunol"},{"key":"3731_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","volume":"16","author":"P Broz","year":"2016","unstructured":"Broz P, Dixit VM. Inflammasomes: mechanisms of assembly, regulation and signalling. Nat Rev Immunol. 2016;16:407\u201320. https:\/\/doi.org\/10.1038\/nri.2016.58.","journal-title":"Nat Rev Immunol"},{"key":"3731_CR4","doi-asserted-by":"publisher","unstructured":"Martiono F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol. 2009;27:229\u2009\u2013\u200965. https:\/\/doi.org\/10.1146\/annurev.immunol.021908.132715.\u00a0","DOI":"10.1146\/annurev.immunol.021908.132715"},{"issue":"22","key":"3731_CR5","doi-asserted-by":"publisher","first-page":"7799","DOI":"10.1074\/jbc.rev119.008907","volume":"295","author":"R Sitia","year":"2020","unstructured":"Sitia R, Rubartelli A. Evolution, role of inflammation, and redox control of leaderless secretory proteins. J Biol Chem. 2020;295(22):7799\u2013811. https:\/\/doi.org\/10.1074\/jbc.rev119.008907.","journal-title":"J Biol Chem"},{"issue":"8","key":"3731_CR6","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.4049\/jimmunol.165.8.4615","volume":"165","author":"DG Perregaux","year":"2000","unstructured":"Perregaux DG, McNiff P, Laliberte R, Conklyn M, Gabel CA. ATP acts as an agonist to promote stimulus-induced secretion of IL-1\u03b2 and IL-18 in human blood. J Immunol. 2000;165(8):4615\u201323. https:\/\/doi.org\/10.4049\/jimmunol.165.8.4615.","journal-title":"J Immunol"},{"issue":"26","key":"3731_CR7","doi-asserted-by":"publisher","first-page":"6299","DOI":"10.1016\/j.cell.2021.11.011","volume":"184","author":"L Andreeva","year":"2021","unstructured":"Andreeva L, David L, Rawson S, Shen C, Pasricha T, Pelegrin P, et al. NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation. Cell. 2021;184(26):6299\u2013312. https:\/\/doi.org\/10.1016\/j.cell.2021.11.011.","journal-title":"Cell"},{"issue":"1","key":"3731_CR8","doi-asserted-by":"publisher","first-page":"7246","DOI":"10.1038\/s41467-023-43180-8","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Zhai H, Alemayehu H, Boulanger J, Hopkins LJ, Borgeaud AC, et al. Cryo-electron tomography of NLRP3-activated ASC complexes reveals organelle co-localization. Nat Commun. 2023;14(1):7246. https:\/\/doi.org\/10.1038\/s41467-023-43180-8.","journal-title":"Nat Commun"},{"key":"3731_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","volume":"41","author":"J Fu","year":"2023","unstructured":"Fu J, Wu H. Structural mechanisms of NLRP3 inflammasome assembly and activation. Annu Rev Immunol. 2023;41:301\u201316. https:\/\/doi.org\/10.1146\/annurev-immunol-081022-021207.","journal-title":"Annu Rev Immunol"},{"issue":"20","key":"3731_CR10","doi-asserted-by":"publisher","first-page":"10964","DOI":"10.1073\/pnas.96.20.10964","volume":"96","author":"GS Salvesen","year":"1999","unstructured":"Salvesen GS, Dixit VM. Caspase activation: the induced-proximity model. Proc Natl Acad Sci USA. 1999;96(20):10964\u201367. https:\/\/doi.org\/10.1073\/pnas.96.20.10964.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3731_CR11","doi-asserted-by":"publisher","first-page":"108753","DOI":"10.1016\/j.abb.2021.108753","volume":"699","author":"NJ Makoni","year":"2021","unstructured":"Makoni NJ, Nichols MR. The intricate biophysical puzzle of caspase-1 activation. Arch Biochem Biophys. 2021;699:108753. https:\/\/doi.org\/10.1016\/j.abb.2021.108753.","journal-title":"Arch Biochem Biophys"},{"key":"3731_CR12","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526:660\u20135. https:\/\/doi.org\/10.1038\/nature15514.","journal-title":"Nature"},{"issue":"12","key":"3731_CR13","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/cr.2015.139","volume":"25","author":"W-t He","year":"2015","unstructured":"He W-t, Wan H, Hu L, Chen P, Wang X, Huang Z, et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1\u03b2 secretion. Cell Res. 2015;25(12):1285\u201398. https:\/\/doi.org\/10.1038\/cr.2015.139.","journal-title":"Cell Res"},{"issue":"11","key":"3731_CR14","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1084\/jem.20190545","volume":"216","author":"P Orning","year":"2019","unstructured":"Orning P, Lien E, Fitzgerald KA. Gasdermins and their role in immunity and inflammation. J Exp Med. 2019;216(11):2453\u201365. https:\/\/doi.org\/10.1084\/jem.20190545.","journal-title":"J Exp Med"},{"issue":"12","key":"3731_CR15","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","volume":"41","author":"Y He","year":"2016","unstructured":"He Y, Hara H, N\u00fa\u00f1ez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci. 2016;41(12):1012\u201321. https:\/\/doi.org\/10.1016\/j.tibs.2016.09.002.","journal-title":"Trends Biochem Sci"},{"issue":"11","key":"3731_CR16","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.cell.2023.04.025","volume":"186","author":"KC Barnett","year":"2023","unstructured":"Barnett KC, Li S, Liang K, Ting JP-Y. A 360o view of the inflammasome: mechanisms of activation, cell death, and diseases. Cell. 2023;186(11):2288\u2013312. https:\/\/doi.org\/10.1016\/j.cell.2023.04.025.","journal-title":"Cell"},{"issue":"8","key":"3731_CR17","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov. 2018;17(8):588\u2013606. https:\/\/doi.org\/10.1038\/nrd.2018.97.","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"3731_CR18","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.4049\/jimmunol.1302484","volume":"192","author":"EO Samstad","year":"2014","unstructured":"Samstad EO, Niyonzima N, Nymo S, Aune MH, Ryan L, Bakke SS, et al. Cholesterol crystals induce complement-mediated inflammasome activation and cytokine release. J Immunol. 2014;192(6):2837\u201345. https:\/\/doi.org\/10.4049\/jimmunol.1302484.","journal-title":"J Immunol"},{"issue":"5","key":"3731_CR19","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1021\/acsptsci.4c00061","volume":"7","author":"JR Doedens","year":"2024","unstructured":"Doedens JR, Smolak P, Nguyen M, Wescott H, Diamond C, Schooley K, et al. Pharmacological analysis of NLRP3 inflammasome inhibitor sodium [(1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)carbamoyl][(1-methyl-1H-pyrazol-4-yl)({[(2S)-oxolan-2-yl]methyl})sulfamoyl]azanide in cellular and mouse models of inflammation provides a translational framework. ACS Pharmacol Trans Sci. 2024;7(5):1438\u201356. https:\/\/doi.org\/10.1021\/acsptsci.4c00061.","journal-title":"ACS Pharmacol Trans Sci"},{"issue":"12","key":"3731_CR20","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridler","year":"2017","unstructured":"Ridler PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with Canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1707914.","journal-title":"N Engl J Med"},{"issue":"10","key":"3731_CR21","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","volume":"19","author":"MT Heneka","year":"2018","unstructured":"Heneka MT, McManus RM, Latz E. Inflammasome signaling in brain function and neurodegenerative disease. Nat Rev Neurosci. 2018;19(10):610\u201321. https:\/\/doi.org\/10.1038\/s41583-018-0055-7.","journal-title":"Nat Rev Neurosci"},{"key":"3731_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.coi.2020.10.011","volume":"68","author":"MT Milner","year":"2021","unstructured":"Milner MT, Maddugoda M, G\u00f6tz J, Burgener SS, Schroder K. The NLRP3 inflammasome triggers sterile neuroinflammation and alzheimer\u2019s disease. Curr Opin Immunol. 2021;68:116\u201324. https:\/\/doi.org\/10.1016\/j.coi.2020.10.011.","journal-title":"Curr Opin Immunol"},{"key":"3731_CR23","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","volume":"61","author":"C Dempsey","year":"2017","unstructured":"Dempsey C, Araiz AR, Bryson KJ, Finucane O, Larkin C, Mills EL, et al. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-\u03b2 and cognitive function in APP\/PS1 mice. Brain Behav Immun. 2017;61:306\u201316. https:\/\/doi.org\/10.1016\/j.bbi.2016.12.014.","journal-title":"Brain Behav Immun"},{"issue":"465","key":"3731_CR24","doi-asserted-by":"publisher","first-page":"eaah4066","DOI":"10.1126\/scitranslmed.aah4066","volume":"10","author":"R Gordon","year":"2018","unstructured":"Gordon R, Albornoz EA, Christie DC, Langley MR, Kumar V, Mantovani S, et al. Inflammasome Inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice. Sci Transl Med. 2018;10(465):eaah4066. https:\/\/doi.org\/10.1126\/scitranslmed.aah4066.","journal-title":"Sci Transl Med"},{"key":"3731_CR25","doi-asserted-by":"publisher","first-page":"108305","DOI":"10.1016\/j.neuropharm.2020.108305","volume":"180","author":"C Hull","year":"2020","unstructured":"Hull C, Dekeryte R, Buchanan H, Kamli-Salino S, Robertson A, Delibegovic M, et al. NLRP3 inflammasome Inhibition with MCC950 improves insulin sensitivity and inflammation in a mouse model of frontotemporal dementia. Neuropharmacology. 2020;180:108305. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108305.","journal-title":"Neuropharmacology"},{"key":"3731_CR26","doi-asserted-by":"publisher","first-page":"149129","DOI":"10.1016\/j.brainres.2024.149129","volume":"1842","author":"A Chatterjee","year":"2024","unstructured":"Chatterjee A, Mohapatra J, Sharma M, Jha A, Patro R, Das D, et al. A novel selective NLRP3 inhibitor shows disease-modifying potential in animal models of parkinson\u2019s disease. Brain Res. 2024;1842:149129. https:\/\/doi.org\/10.1016\/j.brainres.2024.149129.","journal-title":"Brain Res"},{"key":"3731_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s44400-025-00011-5","volume":"1","author":"A Auger","year":"2025","unstructured":"Auger A, Faidi R, Rickman AD, Martinez CP, Fajfer A, Carling J, et al. Post-symptomatic NLRP3 Inhibition rescues cognitive impairment and mitigates amyloid and Tau driven neurodegeneration. Npj Dement. 2025;1:3. https:\/\/doi.org\/10.1038\/s44400-025-00011-5.","journal-title":"Npj Dement"},{"key":"3731_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaf372","author":"EA Albornoz","year":"2025","unstructured":"Albornoz EA, Mardon K, Bhalla R, Kumar V, Stimson DHR, Cowin G, et al. PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in parkinson\u2019s disease models. Brain. 2025. https:\/\/doi.org\/10.1093\/brain\/awaf372.","journal-title":"Brain"},{"key":"3731_CR29","doi-asserted-by":"publisher","unstructured":"Lee SW, de Vivero Vaccari JP, Truettner JS, Dietrich WD, Keane RW. The role of microglial inflammasome activation in pyroptotic cell death following penetrating traumatic brain injury. J Neuroinflammation 2019:16:27. https:\/\/doi.org\/10.1186\/s12974-019-1423-6.","DOI":"10.1186\/s12974-019-1423-6"},{"key":"3731_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21678421.2025.2515900","volume":"13","author":"A Yeole","year":"2025","unstructured":"Yeole A, Khanna L, Doshi M, Sharma A, Uttarwar P, Doshi S, et al. A phase 2, proof-of-concept, placebo-controlled, randomized, multicenter, double-blind study to evaluate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of Usnoflast (ZYIL1) in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2025;13:1\u20138. https:\/\/doi.org\/10.1080\/21678421.2025.2515900.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"3731_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/mds.30307","author":"N Clarke","year":"2025","unstructured":"Clarke N, Thornton P, Reader V, Lindsay N, Digby Z, Mullen B, et al. Anti-neuroinflammatory and anti-inflammatory effects of the NLRP3 inhibitor NT-0796 in subjects with parkinson\u2019s disease. Move Disord. 2025. https:\/\/doi.org\/10.1002\/mds.30307.","journal-title":"Move Disord"},{"issue":"3","key":"3731_CR32","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll RC, Robertson AAB, Chae JJ, Higgins SC, Munoz-lanillo R, Inserra MC, et al. A small molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015;21(3):248\u201355.","journal-title":"Nat Med"},{"issue":"3","key":"3731_CR33","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1124\/pharmrev.120.000171","volume":"73","author":"SE Corcoran","year":"2021","unstructured":"Corcoran SE, Halai R, Cooper MA. Pharmacological Inhibition of the Nod-like receptor family Pyrin domain containing 3 inflammasome with MCC950. Pharmacol Rev. 2021;73(3):968\u20131000. https:\/\/doi.org\/10.1124\/pharmrev.120.000171.","journal-title":"Pharmacol Rev"},{"key":"3731_CR34","doi-asserted-by":"publisher","first-page":"e0130624","DOI":"10.1371\/journal.pone.0130624","volume":"10","author":"A Gustin","year":"2015","unstructured":"Gustin A, Kirchmeyer M, Koncina E, Felten P, Losciuto S, Heurtaux T, et al. NLRP3 inflammasome is expressed and functional in mouse brain microglia but not in astrocytes. PLoS ONE. 2015;10:e0130624. https:\/\/doi.org\/10.1371\/journal.pone.0130624.","journal-title":"PLoS ONE"},{"key":"3731_CR35","doi-asserted-by":"publisher","first-page":"1575453","DOI":"10.3389\/fnins.2025.1575453","volume":"19","author":"J Han","year":"2025","unstructured":"Han J, Zhang Z, Zhang P, Yu Q, Cheng Q, Lu Z, Zong S. The roles of microglia and astrocytes in neuroinflammation of alzheimer\u2019s disease. Front Neurosci. 2025;19:1575453. https:\/\/doi.org\/10.3389\/fnins.2025.1575453.","journal-title":"Front Neurosci"},{"issue":"10","key":"3731_CR36","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/s41593-019-0491-3","volume":"22","author":"M Ximerakis","year":"2019","unstructured":"Ximerakis M, Lipnick SL, Innes BT, Simmons SK, Adiconsi W, Dionne D, et al. Single-cell transcriptomic profiling of the aging mouse brain. Nat Neurosci. 2019;22(10):1696\u2013708. https:\/\/doi.org\/10.1038\/s41593-019-0491-3.","journal-title":"Nat Neurosci"},{"issue":"1","key":"3731_CR37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12974-019-1459-7","volume":"16","author":"W He","year":"2019","unstructured":"He W, Long T, Pan Q, Zhang S, Zhang Y, Zhang D, et al. Microglial NLRP3 inflammasome activation mediates IL-1\u03b2 release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model. J Neuroinflammation. 2019;16(1):78. https:\/\/doi.org\/10.1186\/s12974-019-1459-7.","journal-title":"J Neuroinflammation"},{"issue":"23","key":"3731_CR38","doi-asserted-by":"publisher","first-page":"20776","DOI":"10.1021\/acs.jmedchem.4c02846","volume":"67","author":"D Harrison","year":"2024","unstructured":"Harrison D. Brain penetrant NLRP3 inhibitors: the discovery of a panacea? J Med Chem. 2024;67(23):20776\u201399. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c02846.","journal-title":"J Med Chem"},{"issue":"18","key":"3731_CR39","doi-asserted-by":"publisher","first-page":"13152","DOI":"10.1021\/acs.jmedchem.1c00910","volume":"64","author":"B Xiong","year":"2021","unstructured":"Xiong B. Strategies for structural modification of small molecules to improve blood-brain-barriers penetration: A recent perspective. J Med Chem. 2021;64(18):13152\u201373. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00910.","journal-title":"J Med Chem"},{"key":"3731_CR40","doi-asserted-by":"publisher","DOI":"10.1039\/D5MD00639B","author":"D Harrison","year":"2025","unstructured":"Harrison D, Billinton A, Bock MG, Clarke NP, Digby Z, Gabel CA, et al. Profile of NT-0527, a brain penetrant NLRP3 inflammasome inhibitor suitable as an in vivo tool compound for neuroinflammatory disorders. RSC Med Chem. 2025. https:\/\/doi.org\/10.1039\/D5MD00639B.","journal-title":"RSC Med Chem"},{"issue":"3","key":"3731_CR41","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1021\/acs.molpharmaceut.2c00915","volume":"20","author":"US Ismailani","year":"2023","unstructured":"Ismailani US, Buchler A, MacMullin N, Abdirahman F, Adi M, Rotstein BH. Synthesis and evaluation of [11C]MCC950 for imaging NLRP3-mediated inflammation in atherosclerosis. Mol Pharm. 2023;20(3):1709\u201316. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c00915.","journal-title":"Mol Pharm"},{"issue":"12","key":"3731_CR42","doi-asserted-by":"publisher","first-page":"127186","DOI":"10.1016\/j.bmcl.2020.127186","volume":"30","author":"JR Hill","year":"2020","unstructured":"Hill JR, Shao X, Massey NL, Stauff J, Sherman PS, Robertson AAB, et al. Synthesis and evaluation of NLRP3-inhibitory sulfonylurea [11C]MCC950 in healthy animals. Bioorg Med Chem Lett. 2020;30(12):127186. https:\/\/doi.org\/10.1016\/j.bmcl.2020.127186.","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"3731_CR43","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12974-018-1236-z","volume":"15","author":"C Qiao","year":"2018","unstructured":"Qiao C, Zhang Q, Jiang Q, Zhang T, Chen M, Fan Y, et al. Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP\/p mouse model of parkinson\u2019s disease. J Neuroinflammation. 2018;15(1):193. https:\/\/doi.org\/10.1186\/s12974-018-1236-z.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"3731_CR44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/ng756","volume":"29","author":"HM Hoffman","year":"2001","unstructured":"Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes Familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. 2001;29(3):301\u20135. https:\/\/doi.org\/10.1038\/ng756.","journal-title":"Nat Genet"},{"issue":"1","key":"3731_CR45","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/imr.13292","volume":"322","author":"CD Putnam","year":"2023","unstructured":"Putnam CD, Broderick L, Hoffman HM. The discovery of NLRP3 and its function in cryopyrin-associated periodic syndromes and innate immunity. Immunol Rev. 2023;322(1):259\u201382. https:\/\/doi.org\/10.1111\/imr.13292.","journal-title":"Immunol Rev"},{"issue":"5","key":"3731_CR46","doi-asserted-by":"publisher","first-page":"e20231200","DOI":"10.1084\/jem.20231200","volume":"221","author":"C Cosson","year":"2024","unstructured":"Cosson C, Riou R, Patoli D, Niu T, Rey A, Groslambert M, et al. Functional diversity of NLRP3 gain-of-function mutants associated with CAPS autoinflammation. J Exp Med. 2024;221(5):e20231200. https:\/\/doi.org\/10.1084\/jem.20231200.","journal-title":"J Exp Med"},{"issue":"12","key":"3731_CR47","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1002\/art.10688","volume":"46","author":"I Aksentijevich","year":"2002","unstructured":"Aksentijevich I, Nowak M, Mallah M, Chae JJ, Watford WT, Hofmann SR, et al. De Novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): A new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum. 2002;46(12):3340\u201348. https:\/\/doi.org\/10.1002\/art.10688.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"3731_CR48","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1182\/blood-2003-07-2531","volume":"103","author":"B Neven","year":"2004","unstructured":"Neven B, Callebaut I, Prieur C-A, Feldmann J, Bodemer C, Lepore L, et al. Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA\/NOMID, MWS, and FCU. Blood. 2004;103(7):2809\u201315. https:\/\/doi.org\/10.1182\/blood-2003-07-2531.","journal-title":"Blood"},{"issue":"4","key":"3731_CR49","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/art.22491","volume":"56","author":"I Aksentijevich","year":"2007","unstructured":"Aksentijevich I, Putnam CD, Remmers EF, Mueller JL, Le J, Kolodner RD, et al. The clinical continuum of Cryopyrinopathies: novel CIAS1 mutations in North American patients and a new Cryopyrin model. Arthritis Rheum. 2007;56(4):1273\u201385. https:\/\/doi.org\/10.1002\/art.22491.","journal-title":"Arthritis Rheum"},{"issue":"23","key":"3731_CR50","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/nejmoa0810787","volume":"360","author":"H Lachmann","year":"2009","unstructured":"Lachmann H, Kone-Paut I, Kuemmerle-Deschner JB, Leslie KS, Hachulla E, Quartier P, et al. Use of Canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med. 2009;360(23):2416\u201325. https:\/\/doi.org\/10.1056\/nejmoa0810787.","journal-title":"N Engl J Med"},{"issue":"6","key":"3731_CR51","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/nejmoa055137","volume":"355","author":"R Goldbach-Mansky","year":"2006","unstructured":"Goldbach-Mansky R, Dailey NJ, Canna SW, Gelabert A, Jones J, Rubin BI, et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1\u03b2 Inhibition. N Engl J Med. 2006;355(6):581\u201392. https:\/\/doi.org\/10.1056\/nejmoa055137.","journal-title":"N Engl J Med"},{"key":"3731_CR52","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-med-061512-150641","volume":"65","author":"AA Jesus","year":"2014","unstructured":"Jesus AA, Goldbach-Mansky R. IL-1 Blockade in autoinflammatory syndromes. Ann Rev Med. 2014;65:223\u201344. https:\/\/doi.org\/10.1146\/annurev-med-061512-150641.","journal-title":"Ann Rev Med"},{"issue":"11","key":"3731_CR53","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1016\/j.celrep.2016.11.052","volume":"17","author":"JN Snouwaert","year":"2016","unstructured":"Snouwaert JN, Nguyen M, Repenning PW, Dye R, Livingston EW, Kovarova M, et al. An NLRP3 mutation causes arthropathy and osteoporosis in humanized mice. Cell Rep. 2016;17(11):3077\u201388. https:\/\/doi.org\/10.1016\/j.celrep.2016.11.052.","journal-title":"Cell Rep"},{"issue":"3","key":"3731_CR54","doi-asserted-by":"publisher","first-page":"113852","DOI":"10.1016\/j.celrep.2024.113852","volume":"43","author":"BH Koller","year":"2024","unstructured":"Koller BH, Nguyen M, Snouwaert JN, Gabel CA, Ting JP-Y. Species-specific NLRP3 regulation and its role in CNS autoinflammatory diseases. Cell Rep. 2024;43(3):113852. https:\/\/doi.org\/10.1016\/j.celrep.2024.113852.","journal-title":"Cell Rep"},{"issue":"3","key":"3731_CR55","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1124\/jpet.123.001941","volume":"388","author":"P Smolak","year":"2024","unstructured":"Smolak P, Nguyen M, Diamond C, Wescott H, Doedens JR, Schooley K, et al. Target cell activation of a structurally novel NOD-like receptor Pyrin domain-containing protein 3 inhibitor NT-0796 enhances potency. J Pharmacol Exp Ther. 2024;388(3):798\u2013812. https:\/\/doi.org\/10.1124\/jpet.123.001941.","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"3731_CR56","doi-asserted-by":"publisher","first-page":"87003","DOI":"10.1289\/ehp6943","volume":"128","author":"BH Koller","year":"2020","unstructured":"Koller BH, Snouwaert JN, Douillet C, Jania LA, El-Masri H, Thomas DJ, et al. Arsenic metabolism in mice carrying a BORCS7\/AS3MT locus humanized by syntenic replacement. Environ Health Perspect. 2020;128(8):87003. https:\/\/doi.org\/10.1289\/ehp6943.","journal-title":"Environ Health Perspect"},{"issue":"2","key":"3731_CR57","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.immuni.2018.01.011","volume":"48","author":"D Mrdjen","year":"2018","unstructured":"Mrdjen D, Pavlovic A, Hartmann FJ, Schreiner B, Utz SG, Leung BP, et al. High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease. Immunity. 2018;48(2):380\u201395. https:\/\/doi.org\/10.1016\/j.immuni.2018.01.011.","journal-title":"Immunity"},{"key":"3731_CR58","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jneumeth.2015.03.021","volume":"247","author":"L Legroux","year":"2015","unstructured":"Legroux L, Pittet CL, Beauseigle D, Deblois G, Prat A, Arbour N. An optimized method to process mouse CNS to simultaneously analyze neural cells and leukocytes by flow cytometry. J Neurosci Methods. 2015;247:23\u201331. https:\/\/doi.org\/10.1016\/j.jneumeth.2015.03.021.","journal-title":"J Neurosci Methods"},{"key":"3731_CR59","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.clim.2017.11.011","volume":"191","author":"L Grinstein","year":"2018","unstructured":"Grinstein L, Endter K, Hedrich CM, Reinke S, Luksch H, Schulze F, et al. An optimized whole blood assay measuring expression and activity of NLRP3, NLRC4, and AIM2 inflammasomes. Clin Immunol. 2018;191:100\u20139.","journal-title":"Clin Immunol"},{"issue":"6","key":"3731_CR60","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.molmed.2018.04.003","volume":"24","author":"R Rua","year":"2018","unstructured":"Rua R, McGavern DB. Advances in meningeal immunity. Trends Mol Med. 2018;24(6):542\u2013. https:\/\/doi.org\/10.1016\/j.molmed.2018.04.003. \u200959.","journal-title":"Trends Mol Med"},{"issue":"5","key":"3731_CR61","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/s0002-9440(10)64456-2","volume":"161","author":"A Kato","year":"2002","unstructured":"Kato A, Gabay C, Okaya T, Lentsch AB. Specific role of interleukin-1 in hepatic neutrophil recruitment after ischemia\/reperfusion. Am J Pathol. 2002;161(5):1797\u2013803. https:\/\/doi.org\/10.1016\/s0002-9440(10)64456-2.","journal-title":"Am J Pathol"},{"issue":"1","key":"3731_CR62","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1006\/jsre.1997.5061","volume":"69","author":"AA Parikh","year":"1997","unstructured":"Parikh AA, Salzman AL, Kane CD, Fischer JE, Hasselgren PO. IL-6 production in human intestinal cells following stimulation with IL-1\u03b2 is associated with activation of the transcription factor NF-kappa B. J Surg Res. 1997;69(1):139\u201344. https:\/\/doi.org\/10.1006\/jsre.1997.5061.","journal-title":"J Surg Res"},{"issue":"3","key":"3731_CR63","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/s8756-3282(99)00162-3","volume":"25","author":"LC Hofbauer","year":"1999","unstructured":"Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S. Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone. 1999;25(3):255\u201359. https:\/\/doi.org\/10.1016\/s8756-3282(99)00162-3.","journal-title":"Bone"},{"issue":"1","key":"3731_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-023-01131-9","volume":"56","author":"JE Yu","year":"2023","unstructured":"Yu JE, Yeo IJ, Han S-B, Yun J, Kim B, Yong YJ, et al. Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer. Exp Mol Med. 2023;56(1):1\u201318. https:\/\/doi.org\/10.1038\/s12276-023-01131-9.","journal-title":"Exp Mol Med"},{"issue":"5","key":"3731_CR65","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1084\/jem.20082481","volume":"206","author":"HJ Lachmann","year":"2009","unstructured":"Lachmann HJ, Lowe P, Felix SD, Rordorf C, Leslie K, Madhoo S, et al. In vivo regulation of Interleukin 1\u03b2 in patients with cryopyrin-associated periodic syndromes. J Exp Med. 2009;206(5):1029\u201336. https:\/\/doi.org\/10.1084\/jem.20082481.","journal-title":"J Exp Med"},{"key":"3731_CR66","doi-asserted-by":"publisher","first-page":"805657","DOI":"10.3389\/fimmu.2022.805657","volume":"13","author":"JA Mapunda","year":"2022","unstructured":"Mapunda JA, Tibar H, Regragui W, Engelhardt B. How does the immune system enter the brain. Front Immunol. 2022;13:805657. https:\/\/doi.org\/10.3389\/fimmu.2022.805657.","journal-title":"Front Immunol"},{"issue":"1","key":"3731_CR67","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00401-023-02676-9","volume":"147","author":"AD Gasull","year":"2024","unstructured":"Gasull AD, Glavan M, Samawar SKR, Kapupara K, Kelk J, Rubio M, et al. The niche matters: origin, function and fate of CNS-associated macrophages during health and disease. Acta Neuropathol. 2024;147(1):37. https:\/\/doi.org\/10.1007\/s00401-023-02676-9.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"3731_CR68","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ncb3346","volume":"18","author":"EM Pietras","year":"2016","unstructured":"Pietras EM, Mirantes-Barbeito C, Fong S, Loeffler D, Kovtonyuk L, Zhang S, et al. Chronic interleukin-1 exposure drives Haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal. Nat Cell Biol. 2016;18(6):607\u201318. https:\/\/doi.org\/10.1038\/ncb3346.","journal-title":"Nat Cell Biol"},{"issue":"6","key":"3731_CR69","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/art.40055","volume":"69","author":"J Rodriguez-Smith","year":"2017","unstructured":"Rodriguez-Smith J, Lin Y-C, Tsai WL, Kim H, Montealegre-Sanchez G, Chapelle D, et al. Cerebrospinal fluid cytokines correlate with aseptic meningitis and blood-brain barrier function in neonatal-onset multisystem inflammatory disease: central nervous system biomarkers in neonatal-onset multisystem inflammatory disease correlate with central nervous system inflammation. Arthritis Rheumatol. 2017;69(6):1325\u201336. https:\/\/doi.org\/10.1002\/art.40055.","journal-title":"Arthritis Rheumatol"},{"key":"3731_CR70","doi-asserted-by":"publisher","first-page":"100307","DOI":"10.1016\/j.bbih.2021.100307","volume":"16","author":"EO Sj\u00f6strom","year":"2021","unstructured":"Sj\u00f6strom EO, Gulot M, Leickt L, \u00c5strand M, Nordling E, Gosselet F, et al. Transport study of interleukin-1 inhibitors using a human in vitro model of the blood-brain barrier. Brain Behav Immun Health. 2021;16:100307. https:\/\/doi.org\/10.1016\/j.bbih.2021.100307.","journal-title":"Brain Behav Immun Health"},{"issue":"6753","key":"3731_CR71","doi-asserted-by":"publisher","first-page":"eadx0043","DOI":"10.1126\/science.adx0043","volume":"388","author":"F-D Shi","year":"2025","unstructured":"Shi F-D, Yong VW. Neuroinflammation across neurological disorders. Science. 2025;388(6753):eadx0043.","journal-title":"Science"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03731-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03731-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03731-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:16:50Z","timestamp":1774617410000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03731-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,21]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3731"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03731-4","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,21]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mouse model studies were conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals and the Institutional Animal Care and Use Committee guidelines for the University of North Carolina at Chapel Hill.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NC, APW, and DH are current employees of NodThera; JD and CAG are former NodThera employees. BHK and MN have no competing interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}